Study Information

Title: A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013)(KEYNOTE-013) External
Status: Recruiting participants
Conditions: Myelodysplastic Syndrome; Multiple Myeloma; Hodgkin's Lymphoma; Non-Hodgkin's Lymphoma
Interventions: Biological: Pembrolizumab
Health Topics: Hodgkin Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Non-Hodgkin Lymphoma

Contact Information


Call for Information (Investigational Site 0001)
Boston, MA 02215
Call for Information (Investigational Site 0002)
Boston, MA 02215